Tag: Abbott
Studies link Abbott CGM with reduced hospitalizations
May 19, 2025HME News Staff
ABBOTT PARK, Ill. – Abbott’s FreeStyle Libre continuous glucose monitoring technology is associated with a significant reduction in the risk of hospitalization for heart complications in people with diabetes, according to the results of the company’s REFLECT real-world studies.
For the first time, Abbott says, data show that CGM technology can help lessen the severity of cardiovascular complications – regardless of a prior history of low blood sugar events or heart...
In brief: Abbott integrates with Epic, NCPA appeals to DOGE, AAH calls for advocates
April 30, 2025HME News Staff
ABBOTT PARK, Ill. – Abbott has entered a first-of-its-kind agreement to integrate data from FreeStyle Libre CGM systems directly into Epic electronic health record systems in the United States, allowing clinicians to view data from within the systems before, during and after meeting with patients.
The collaboration aims to improve workflow efficiency through Epic’s Aura software, which brings health systems together with diagnostic labs and medical device manufacturers.
"Our...
Abbott integrates Libre data with Epic EHR system
April 29, 2025HME News Staff
ABBOTT PARK, Ill. – Abbott has entered a first-of-its-kind agreement to integrate data from FreeStyle Libre CGM systems directly into Epic electronic health record systems in the United States, allowing clinicians to view data from within the systems before, during and after meeting with patients.
The collaboration aims to improve workflow efficiency through Epic’s Aura software, which brings health systems together with diagnostic labs and medical device manufacturers.
"Our...
Medtronic seeks FDA clearance for pump
April 24, 2025HME News Staff
GALWAY, Ireland – Medtronic has submitted 510(k) applications to the U.S. Food and Drug Administration seeking clearance for an interoperable pump. FDA clearance of this pump would pave the way for system integration with a continuous glucose monitoring (CGM) sensor based on Abbott's most advanced CGM platform. The submissions included a 510(k) application for its MiniMed 780G pump as an alternate controller enabled (ACE) insulin pump and a separate 510(k) application for its SmartGuard...
In brief: Numotion reports data incident, Abbott launches app
April 23, 2025HME News Staff
PHOENIX - Numotion recently learned that certain employee email accounts were accessed without authorization on several occasions between Sept. 2, 2024, and Nov. 18, 2024, the company said in a Notice of Data Security Incident posted on its website.
In the notice, the company states: “Numotion has no reason to believe that anyone was trying to access personal information in the accounts, and there is no indication that any information has been used for fraud or identity theft....
Sequel Med Tech collaborates with Abbott
March 19, 2025HME News Staff
MANCHESTER, N.H. – Sequel Med Tech has announced that Abbott’s FreeStyle Libre 3 Plus sensor will be the first continuous glucose monitoring device to work with its twiist Automated Insulin Delivery (AID) System powered by Tidepool. The sensor will be compatible with twiist when the system is expected to launch in the second quarter of 2025. “We are thrilled to announce our collaboration with Abbott, integrating its world-leading FreeStyle Libre technology as our first CGM partner,...
In brief: Trump turnaround, Homecare Champion finalists, TrueAire recall
February 7, 2025HME News Staff
WASHINGTON - President Donald Trump on Feb. 3 suspended his plans to implement 25% tariffs on products from Mexico and Canada, agreeing to a one-month pause in exchange for concessions on border security and crime enforcement.
The DME industry is closely monitoring the situation to see what, if any, exclusions might be included for medical equipment and products, according to a bulletin from VGM Government Relations.
An increase in tariffs, VGM says, could lead to several...
Abbott launches initiative to battle diabetes misconceptions
February 6, 2025HME News Staff
ABBOTT PARK, Ill. – Abbott has launched Above the Bias, a global initiative to drive awareness about the health impact that common misconceptions and bias about diabetes can have on people living with the condition.
The initiative includes results from a new survey and a film that highlights how everyday comments impact people with diabetes.
"How many times have we heard ‘That looks like diabetes on a plate’ when we’re watching a movie, eating at a restaurant...
In brief: Medline’s IPO, GLP-1's expansion, DME’s ‘hidden cost,’ Nymbl’s investment
January 3, 2025HME News Staff
NORTHFIELD, Ill. – Medline has confidentially submitted a draft registration statement on Form S-1 to the U.S. Securities and Exchange Commission for a proposed initial public offering of its common stock.
The number of shares to be offered and the price range for the proposed offering have not yet been determined. The offering is subject to market and other conditions and the completion of the SEC's review process.
In 2021, Medline announced it had received outside...
Abbott, DexCom settle patent disputes
January 2, 2025HME News Staff
SAN DIEGO and ABBOTT PARK, Ill. – DexCom and Abbott Diabetes Care have entered into a settlement and patent cross license agreement to resolve all outstanding patent litigation between the parties related to their continuous glucose monitors, according to a Form 8-K filed by Dexcom with the U.S. Securities and Exchange Commission. Both companies have accused the other of infringing certain patents and each company has filed counterclaims and actions to invalidate the other’s patents....